Bank of New York Mellon
ANAC

Bank of New York Mellon’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bank of New York Mellon’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-460,299
Closed -$24.6M – 4443
2016
Q1 		$24.6M Sell
460,299
-220,914
-32% -$16.3M 0.01% 1280
2015
Q4 		$77M Buy
681,213
+212,115
+45% +$23.4M 0.02% 654
2015
Q3 		$55.2M Buy
469,098
+216,379
+86% +$28.3M 0.02% 786
2015
Q2 		$19.6M Sell
252,719
-334,847
-57% -$22M 0.01% 1498
2015
Q1 		$34M Sell
587,566
-461,700
-44% -$19.6M 0.01% 1117
2014
Q4 		$33.8M Sell
1,049,266
-145,686
-12% -$4.37M 0.01% 1114
2014
Q3 		$29.2M Buy
1,194,952
+601,401
+101% +$12.2M 0.01% 1183
2014
Q2 		$10.5M Buy
593,551
+72,541
+14% +$1.17M ﹤0.01% 1894
2014
Q1 		$10.4M Buy
521,010
+326,657
+168% +$6.33M ﹤0.01% 1882
2013
Q4 		$3.26M Buy
194,353
+88
+0% +$1.22K ﹤0.01% 2565
2013
Q3 		$2.06M Buy
194,265
+77,069
+66% +$674K ﹤0.01% 2838
2013
Q2 		$655K Buy
+117,196
New +$710K ﹤0.01% 3394

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Bank of New York Mellon's ANAC Position: Q2 2016 in Review

Bank of New York Mellon sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 460,299 shares — an estimated $24.6M sold.

Bank of New York Mellon first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $77M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Bank of New York Mellon reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 460,299 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $24.6M.
  • Bank of New York Mellon first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Bank of New York Mellon's ANACOR PHARMACEUTICALS INC COM position peaked at $77M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Bank of New York Mellon's 13F filing for Q2 2016, filed 1 Aug 2016.